PA
CORZ icon

Parallel Advisors’s Core Scientific CORZ Stock Holding History

Parallel Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.5K Buy
800
+266
+50% +$6.26K ﹤0.01% 2612
2026
Q1 		$7.99K Sell
534
-127
-19% -$2.17K ﹤0.01% 2854
2025
Q4 		$9.62K Buy
661
+256
+63% +$4.46K ﹤0.01% 2621
2025
Q3 		$7.27K Buy
405
+5
+1% +$73 ﹤0.01% 2639
2025
Q2 		$6.83K Buy
400
+321
+406% +$3.21K ﹤0.01% 2629
2025
Q1 		$572 Sell
79
-2
-2% -$23 ﹤0.01% 3219
2024
Q4 		$1.14K Buy
81
+19
+31% +$281 ﹤0.01% 3089
2024
Q3 		$735 Buy
+62
New +$642 ﹤0.01% 3103

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Parallel Advisors's CORZ Position: Q2 2026 in Review

Parallel Advisors increased its Core Scientific (CORZ) stake by 50% in Q2 2026, buying an estimated $6.26K and bringing the position to 800 shares worth $20.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2612.

Parallel Advisors first reported a position in CORZ in Q3 2024 and has held it in 8 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Parallel Advisors held 800 shares of Core Scientific worth $20.5K as of Q2 2026.
  • Parallel Advisors bought 266 Core Scientific shares in Q2 2026, an estimated $6.26K.
  • Core Scientific made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2612 holding.
  • Parallel Advisors first reported a position in Core Scientific in Q3 2024 and has held it in 8 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.